FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
Kraft Heinz considers spinning off a significant portion of its grocery business, including many Kraft-branded products, into a new entity valued at up to $20 billion.
US imposes sanctions on Cuban officials for 2021 crackdown on anti-government protests.
FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
Kraft Heinz considers spinning off a significant portion of its grocery business, including many Kraft-branded products, into a new entity valued at up to $20 billion.
US imposes sanctions on Cuban officials for 2021 crackdown on anti-government protests.